Loading...

Penumbra, Inc.

PENNYSE
Healthcare
Medical - Devices
$233.10
$2.92(1.27%)

Penumbra, Inc. (PEN) Stock Overview

Explore Penumbra, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 76.1/100

Key Financials

Market Cap9B
P/E Ratio212.72
EPS (TTM)$1.07
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Week$245.80
1 Month$243.49
3 Months$290.70
1 Year Target$241.30

PEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Penumbra, Inc. (PEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $241.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 212.72 and a market capitalization of 9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;